In terms of other stratification factors such as age, gender, radiotherapy status and MGMT methylation status in glioma patients, higher expressions of LOXs were significantly associated with older age and MGMT unmethylated status (Figures 3A,D) while no evident correlation was observed concerning the relationship between LOXs expressions and gender or radiotherapy status (Figures 3B,C). Here, MGMT is linked to central nervous system cancer.